Dr. Matthew Ng
Claim this profileOncocare Cancer Centre
Studies Adenocarcinoma
Studies Stomach Tumors
2 reported clinical trials
6 drugs studied
Area of expertise
1Adenocarcinoma
Stage III
Stage IV
HER2 positive
2Stomach Tumors
Stage III
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Matthew Ng is currently running
Irinotecan + FOLFOX Chemotherapy
for Rectal Cancer
This trial is testing different treatments in patients with advanced rectal cancer to see which one is more effective at shrinking the tumor or stopping its growth, potentially avoiding surgery.
Recruiting1 award Phase 2
Zanidatamab + Chemotherapy ± Tislelizumab
for Stomach and Esophageal Cancer
This trial is testing zanidatamab combined with chemotherapy, and sometimes with another drug called tislelizumab, to see if it works better than the current treatment. It targets patients with advanced HER2-positive stomach and esophageal cancers that can't be treated with surgery or standard treatments. The goal is to help the immune system find and destroy cancer cells more effectively. Zanidatamab is a novel HER2-targeting agent being evaluated for its efficacy in advanced HER2-positive cancers.
Recruiting2 awards Phase 3
More about Matthew Ng
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Matthew Ng has experience with
- Oxaliplatin
- Cisplatin
- Tislelizumab
- Trastuzumab
- Zanidatamab
- Irinotecan
Breakdown of trials Matthew Ng has run
Gastroesophageal Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Ng specialize in?
Matthew Ng focuses on Adenocarcinoma and Stomach Tumors. In particular, much of their work with Adenocarcinoma has involved Stage III patients, or patients who are Stage IV.
Is Matthew Ng currently recruiting for clinical trials?
Yes, Matthew Ng is currently recruiting for 2 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Matthew Ng has studied deeply?
Yes, Matthew Ng has studied treatments such as Oxaliplatin, Cisplatin, Tislelizumab.
What is the best way to schedule an appointment with Matthew Ng?
Apply for one of the trials that Matthew Ng is conducting.
What is the office address of Matthew Ng?
The office of Matthew Ng is located at: George Washington University Medical Center, Washington, District of Columbia 20037 United States. This is the address for their practice at the George Washington University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.